New York, United States, July 11, 2022 (GLOBE NEWSWIRE) — The market is driven by a rising number of patients with cardiovascular diseases, increased prevalence of arrhythmias due to COVID-19, and an overall rise in patients suffering from chronic diseases such as cancer, diabetes, and obesity.
Critical Insights into the market:
- By Product, the Holter monitor had the highest market share.
- By type, defibrillators dominated the market share.
- By End-User, hospitals commanded the maximum share in the market.
- By Region, North America held the majority of the market.
To get a first-hand overview of the report, Request a Sample at
https://www.strategicmarketresearch.com/request-sample/cardiac-arrhythmia-monitoring-devices-market
Factors that are driving the market growth of the Cardiac Arrhythmia Monitoring Devices:
Increase in the number of patients suffering from cardiovascular diseases
An exponential rise of people who suffer from cardiovascular diseases (CVDs) has been noted worldwide. As stated by WHO, more than 17.9 million deaths are due to CVDs, which is approximately 32% of all deaths. According to the European Commission, CVD accounts for 45% of all deaths in Europe. As per the CDC, heart disease leads as the primary cause of death in the country. China had over 5 million deaths due to CVD. The American Heart Association approximates that 82.6 million citizens suffer from at least one form of CVD. Therefore, with the rising prevalence of CVDs, the market for…
